Regencell Bioscience Holdings Balance Sheet (2020-2025) | RGC

Balance Sheet Jun2020 Jun2021 Jun2022 Jun2023 Jun2024 Jun2025 Dec2025
Assets
Current Assets
Cash & Equivalents (Quarter) 0.39M0.06M6.42M1.56M2.96M
Short-term Investments (Quarter) 10.00M10.00M5.00M2.48M
Cash & Current Investments (Quarter) 0.39M0.06M16.42M11.56M7.96M2.48M
Receivables - Other (Quarter) 3.07M3.68M0.01M
Prepaid Assets (Quarter) 0.01M0.03M0.06M0.15M0.01M
Current Assets (Quarter) 0.39M-0.27M-1.57M11.62M-0.32M4.90M2.36M
Non-Current Assets
Property, Plant & Equipment (Net) (Quarter) 0.11M0.08M0.71M0.44M0.14M0.22M0.18M
Other Non-Current Assets (Quarter) 0.02M0.02M0.11M0.11M0.10M0.85M0.66M
Non-Current Assets (Quarter) 0.13M0.27M1.57M1.00M0.32M0.85M-2.36M
Assets (Quarter) 0.51M12.62M5.76M
Liabilities
Current Liabilities
Accounts Payables (Quarter) 0.08M0.02M
Notes Payables (Quarter) 3.25M0.02M0.01M0.01M0.00M
Payables (Quarter) 3.33M0.03M0.01M0.01M0.00M
Accumulated Expenses (Quarter) 0.10M0.57M0.15M0.16M0.13M0.35M
Short term Debt (Quarter) 3.07M0.43M
Current Leases (Quarter) 0.41M0.44M0.06M0.31M0.26M
Total Current Liabilities (Quarter) 3.16M4.34M0.58M0.61M0.19M0.66M1.67M
Non-Current Liabilities
Minority Interest (Quarter) 0.02M-0.04M
Operating Leases (Quarter) 0.36M0.03M0.03M0.23M0.13M
Total Liabilities (Quarter) 3.16M4.34M0.94M0.63M0.22M0.90M1.79M
Shareholder's Equity
Total Debt (Quarter) 3.07M0.43M
Common Equity (Quarter) -2.65M-4.00M17.08M11.99M8.22M4.86M
Shareholder's Equity (Quarter) -2.65M-4.00M17.08M11.99M8.22M4.86M1.22M
Liabilities and Shareholders Equity (Quarter) 0.51M12.62M5.76M
Retained Earnings (Quarter) -2.65M-4.00M-11.44M-17.32M-21.62M-25.20M-30.52M